Page 91 - Sohini Das

Bharat Biotech signs deal with Brazilian wholesaler to supply Covaxin

Quantum of doses to be exported not known

Pfizer compiling data to answer DCGI queries on coronavirus vaccine

Drug major clarifies it could not present itself before the SEC because of short notice and time zone issues

Govt inks pact, first consignment of Covid-19 vaccines to fly today

Serum to supply 11 mn doses at Rs 200 each initially

From factory to front line, all roads lead to Covid-19 vaccine roll-out

According to sources, a contract may be signed between the government and the vaccine makers on Monday, and the first batch of vaccinations will be done using Serum Institute's (SII's) Covishield

Activists raise red flag around Bharat Biotech's Covaxin trial in Bhopal

Write to PM and health minister, call for an independent inquiry

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities

V G Somani: The DCGI chief, a man known by his actions, 'not of words'

To the media, Somani may be a man of few words but among peers he's known for quick responses

PM Modi meet with CMs to kickstart mega Covid-19 vaccination drive

The government is in the final stages of due diligence to ink a supply deal with Serum Institute of India and Bharat Biotech, which have got approval for emergency use of their vaccines

Serum Institute may supply around 400 million more doses to Gavi-Covax

Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose

Airlines get ready for Covid-19 vaccine journey ahead of inoculation drive

Government has asked airlines to get ready to transport 30 tonnes of vaccines immediately

Covid-19 vaccine: Bharat Biotech completes recruitment for phase 3 trials

More than 5,000 people have been given both shots of the vaccine; efficacy data around March

Bharat Biotech vaccine may cost less than Serum's; govt working on pricing

The final contract is expected to be signed soon

Domestic drug market bounces back in Dec, ends CY20 with 3.1% growth

Clocks 8.5% growth in December, up sharply from November's 1% due to revival in volume growth

Next big bet: Experts bullish on Bharat Biotech's upcoming nasal vaccine

Bharat Biotech is currently working on two intra-nasal vaccines

Vaccine firms Bharat Biotech, Serum Institute patch up after war of words

Adar Poonawalla and Krishna Ella issue joint statement saying they would work together to roll out Covid-19 vaccine

Govt clears air on Bharat Biotech's vaccine, says relied on safety data

Minutes of expert panel meeting made public

Bharat Biotech chief takes on Serum Institute in Covid-19 vaccine war

Krishna Ella turns the tables on critics, questions approval granted to Oxford-Astra vaccine

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race

It took a chance by ramping up capacity on vaccines when they were yet to be approved and is set to emerge a global winner

Controversy around Bharat Biotech's Covaxin approval without efficacy data

Bharat Biotech's Covaxin is based on a whole inactivated virus platform, an old technology which is used to make vaccines given to infants